10-Q: Globalink Faces Liquidity Crunch, Delisting Amidst SPAC Merger Delays

Globalink Investment Inc. reports a significant net loss and working capital deficit, with its Nasdaq listing terminated and a critical business combination facing ongoing challenges and redemptions.

Summary

• Net loss for the six months ended June 30, 2025, significantly worsened to $(1,632,451) from $(592,492) for the same period in 2024.
• Cash outside the Trust Account decreased to $22,170 as of June 30, 2025, from $253,507 at December 31, 2024.
• The company has a working capital deficit of approximately $7.9 million, raising substantial doubt about its ability to continue as a going concern.
• Nasdaq delisted the company's securities on May 19, 2025, which are now quoted on the OTC Pink market.
• The business combination with Alps Global Holding Pubco and Alps Life Sciences Inc. has been extended multiple times, with the current termination date set for September 9, 2025, with options for further extension to December 9, 2025.
• Significant redemptions of public shares have occurred, leaving only 72,601 public shares outstanding as of June 30, 2025.
• The company faces a substantial excise tax liability of $1,600,984, including $370,693 in interest and penalties, related to prior redemptions.
• Initial PIPE investment agreements totaling $40.2 million were terminated, replaced by new agreements for $3,479,911, of which $1,124,361 has been received in escrow.
• Promissory notes from related parties total $4,570,422, with an amendment converting a portion to PubCo shares and $2 million payable in cash post-closing.
• Promissory notes from a third party (Dr. Tham Seng Kong) total $450,000 as of June 30, 2025, increasing to $650,000 post-period.
• Management identified material weaknesses in internal controls over financial reporting related to complex financial instruments, tax filings, EPS, and redemption reporting.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including a significant net loss, critical liquidity issues, and a substantial working capital deficit. The Nasdaq delisting, high redemption rates, and termination of a large PIPE investment reflect a lack of market confidence and significant operational challenges. While efforts are ongoing to complete a business combination, the 'going concern' warning and internal control weaknesses paint a very negative picture.

Positives

• Secured multiple extensions for the business combination, pushing the deadline to September 9, 2025, with potential for further extension to December 9, 2025.
• Successfully amended the Merger Agreement to remove the earn-out provision and the $5,000,001 net tangible asset requirement, simplifying closing conditions.
• Amended the underwriting agreement to satisfy the $5,025,000 fee through a transfer of Alps Holdco shares, rather than cash, upon closing, contingent on the business combination closing by July 31, 2025, or a mutually agreed date.
• Recovered $397,214 of the $563,108 overpayment from December 2024 redemptions.
• Recognized a gain of $940,847 from the modification of terms of promissory notes and advances from affiliates.

Negatives

• Net loss significantly increased to $(1,632,451) for the six months ended June 30, 2025, compared to $(592,492) for the same period in 2024.
• Cash outside the Trust Account is critically low at $22,170, indicating severe liquidity constraints for ongoing operations.
• A working capital deficit of approximately $7.9 million raises substantial doubt about the company's ability to continue as a going concern.
• Nasdaq delisted the company's securities on May 19, 2025, leading to trading on the less liquid OTC Pink market.
• Interest income on cash held in the Trust Account decreased substantially to $66,336 for the six months ended June 30, 2025, from $687,312 in the prior year.
• Interest expense surged to $(736,826) for the six months ended June 30, 2025, from $(76,997) in the prior year.
• Accrued excise tax liability, including interest and penalties, reached $1,600,984, with $370,693 in interest and penalties alone.
• Initial PIPE investment agreements totaling $40.2 million were terminated, replaced by significantly smaller commitments of $3,479,911.
• Overpaid redeeming shareholders by $23,067 in July 2025, with no assurance of recovery.
• Identified material weaknesses in internal control over financial reporting related to complex financial instruments, tax filings, EPS, and redemption reporting.

Risks

• Substantial doubt about the ability to continue as a going concern due to mandatory liquidation if a business combination is not consummated by September 9, 2025 (or December 9, 2025 with extensions) and severe liquidity constraints.
• No assurance that the company will successfully effect a business combination, which would lead to liquidation and potential loss of investment for remaining shareholders.
• Inability to raise additional capital through loans or investments from the sponsor, stockholders, officers, directors, or third parties, potentially requiring curtailing operations or suspending transaction pursuit.
• Significant and growing excise tax liability ($1,600,984), including penalties and interest, which could reduce cash available for a business combination.
• Delisting from Nasdaq to the less liquid OTC Pink market, potentially impacting investor interest and future capital raising efforts.
• Issuance of additional shares in connection with a business combination may significantly dilute existing equity interests.
• Incurring significant debt could lead to default, acceleration of obligations, and limitations on financial flexibility.
• No assurances of recovering overpaid amounts to redeeming shareholders.
• Material weaknesses in internal controls over financial reporting could lead to further financial misstatements or compliance issues.
• Risk of being deemed an unregistered investment company if funds are not managed appropriately.
• Potential negative impact from inflation, rising interest rates, financial market instability, potential government shutdown, lingering effects of the COVID-19 pandemic, and geopolitical events on financial position and ability to complete a business combination.

Future Outlook

The company intends to complete a business combination with Alps Holdco before the mandatory liquidation date of September 9, 2025, or December 9, 2025 if further extensions are exercised. It expects to continue incurring significant costs in pursuit of this acquisition. The PIPE investment aims to raise additional capital for PubCo post-closing, and PubCo is obligated to file a registration statement for resale of PIPE shares within 60 days of closing. Management acknowledges substantial doubt about its ability to continue as a going concern if the business combination is not consummated and additional financing is not secured.

Management Comments

• "Management has determined that the mandatory liquidation, should a business combination not occur, and an extension is not requested by the sponsor, and potential subsequent dissolution as well as liquidity condition noted above raises substantial doubt about the Companys ability to continue as a going concern."
• "The Company intends to complete a business combination before the mandatory liquidation date."
• "The Company will make efforts recover the $23,067, $0.11 per share overpayment, however there are no assurances of recovery."
• "We plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our unaudited condensed consolidated financial statements."
• "Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications."
• "Additionally, the Company is implementing deeper review of its common stock subject to possible redemption, by internally reviewing to ensure amounts due to our public stockholders is properly reported."

Industry Context

Globalink operates as a Special Purpose Acquisition Company (SPAC) in a challenging market environment characterized by increased regulatory scrutiny, higher redemption rates, and difficulty in securing PIPE financing. The company's repeated extensions and significant redemptions are indicative of broader trends in the SPAC market where many blank check companies struggle to complete business combinations within their initial timelines. The delisting from Nasdaq to OTC Pink further highlights the difficulties faced by SPACs that fail to meet listing requirements or complete mergers promptly. The target industries, medical technology and green energy, are generally attractive, but the company's operational and financial challenges overshadow the potential of the underlying business combination.

Comparison to Industry Standards

• The high redemption rates (over 99% of initial public shares redeemed by June 30, 2025) are significantly higher than the average SPAC redemption rates observed in recent years, which typically range from 50-80%, indicating a strong lack of investor confidence in the proposed business combination or the SPAC structure itself.
• The termination of a $40.2 million PIPE agreement and its replacement with a much smaller $3.48 million commitment is a stark contrast to successful SPACs that often secure substantial PIPE investments to bolster their balance sheets and provide deal certainty.
• The delisting from Nasdaq to the OTC Pink market is a severe negative deviation from industry standards, as a primary benefit of SPACs is access to major exchange listings, which provides liquidity and investor visibility.
• The repeated extensions of the business combination deadline, now to September 2025 (with potential for December 2025), far exceed the typical 18-24 month initial timeline for SPACs, signaling prolonged difficulties in closing a deal.
• The identified material weaknesses in internal controls over financial reporting are below industry best practices for public companies, raising concerns about financial transparency and reliability.

Management Changes

Corporate Governance

Legal Proceedings

• None.

Related Party Transactions

• Public Gold Marketing Sdn. Bhd. (related party due to familial relationship with sponsor's controlling member) purchased 570,000 Private Placement Units for $5,700,000.
• Public Gold Marketing Sdn. Bhd. provided multiple promissory notes totaling $4,570,422 (principal and interest as of June 30, 2025) for extension fees and working capital, bearing 6% interest.
• An affiliate of the sponsor advanced $390,000 to the company for extension payments, which was later amended to include a conversion option into PubCo ordinary shares at $10.00 per share.
• The company's CEO deposited $60,000 into the Trust Account for extension fees.
• The administrative services agreement with the sponsor, which required $10,000 per month, was terminated on September 30, 2023, with $217,000 accrued as 'Due to affiliate'.

Stakeholder Impact

• Shareholders: Existing public shareholders have experienced significant dilution through redemptions and the delisting to OTC Pink, reducing liquidity and potentially value. Those who redeemed received their pro-rata share from the Trust Account. Remaining shareholders face uncertainty regarding the business combination and the company's going concern status.
• PIPE Investors: New PIPE investors are committing capital at $10.00 per share, potentially at a discount to the redemption value, but face risks associated with the completion of the business combination and the company's financial health.
• Underwriters (Chardan): Their deferred fees are contingent on the business combination closing, with an amendment to receive Alps Holdco shares instead of cash, tying their compensation directly to the merger's success.
• Creditors (Promissory Note Holders): Related party creditors (Public Gold Marketing Sdn. Bhd.) have a portion of their debt convertible into PubCo shares, aligning their interests with the merger's success, while a portion is due in cash post-closing. Third-party creditors (Dr. Tham Seng Kong) are also awaiting the business combination for repayment.
• Management/Sponsor: The sponsor and management have provided significant financial support through loans and advances, indicating a vested interest in completing the business combination, but also bear the risk of non-repayment if the merger fails.

Next Steps

• Complete the business combination with Alps Holdco by September 9, 2025, or by December 9, 2025, if further extensions are exercised.
• File a registration statement for the resale of PIPE Shares within 60 days of the Business Combination's closing.
• Continue efforts to recover overpaid amounts from redeeming shareholders.
• Implement enhanced processes to address material weaknesses in internal control over financial reporting, including improved accounting literature access, communication, and review of common stock redemption reporting.
• Raise additional capital through loans or investments if the business combination is not consummated.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a substantial net loss, critically low cash reserves, and a significant working capital deficit, leading to a 'going concern' warning. The delisting from Nasdaq to the illiquid OTC Pink market severely limits investor access and price discovery. High redemption rates indicate a strong lack of confidence from public shareholders. The termination of a large PIPE investment and the ongoing delays in completing the business combination with Alps Holdco further highlight the precarious situation. While management is attempting to close the merger, the cumulative negative factors, including mounting excise tax liabilities and identified material weaknesses in internal controls, present an exceptionally high-risk profile with little upside potential for current investors. The company's ability to even survive as an operating entity is in question, making it a strong sell.

Keywords

SPAC, Blank Check Company, Business Combination, Merger Agreement, Alps Global Holding Pubco, Alps Life Sciences Inc, Liquidity, Going Concern, Nasdaq Delisting, OTC Pink, Redemptions, PIPE Investment, Promissory Notes, Excise Tax, Internal Controls, Financial Reporting, Medical Technology, Green Energy